Leukostasis and hyperviscosity: when thick blood is the emergency
- Haematological emergency
Blood thickened by too many white cells or too much antibody can block the small vessels of the lungs, brain and eyes. It needs treatment within hours.
What it is
Leukostasis is the blocking of small vessels by large, rigid leukaemic blasts, usually when the blast count is very high (hyperleukocytosis, often above 100 × 10⁹/L). It mainly affects the lungs and brain and is most common in AML, especially monocytic types. Hyperviscosity syndrome is the same problem caused by excess protein, most often IgM in Waldenström macroglobulinaemia, less often IgA or IgG in myeloma. Both reduce flow through small vessels and cause hypoxia, neurological signs and bleeding.
How to recognise it
- Lungs: breathlessness, low oxygen, diffuse infiltrates; brain: headache, confusion, drowsiness, stroke; eyes: blurred vision, retinal haemorrhages and swollen, sausage-like veins.
- AML blasts cause leukostasis at lower counts than ALL; CLL rarely does, even at very high counts, because its small lymphocytes are deformable.
- Protein hyperviscosity: IgM is large and stays in the vessels, so Waldenström is the classic cause; also IgA myeloma, which forms polymers.
- Mucosal bleeding (nose, gums), headache, blurred vision and confusion form the classic hyperviscosity picture; heart failure can follow.
- High cell counts can falsely raise potassium and falsely lower blood oxygen and glucose in the test tube, because the cells keep consuming in the sample.
- Leukostasis often comes with DIC and tumour lysis, especially in AML; APL with a high count is a separate, bleeding-prone emergency.
What to do at once (and why)
- Recognise it: very high blasts or a known paraprotein with breathlessness, confusion, visual change or mucosal bleeding.
- Call haematology the same hour; these patients need intensive monitoring.
- Leukostasis: start cell reduction at once, with hydroxyurea or induction chemotherapy, because blasts must fall quickly.
- Leukapheresis can be considered in selected patients with symptoms; it is avoided in APL because it can worsen bleeding.
- Protein hyperviscosity: plasma exchange removes the paraprotein quickly, then treat the underlying clone.
- Hold red cell transfusion until the count or protein is lowered, as extra red cells thicken the blood; transfuse only for severe symptomatic anaemia.
- Hydrate, prevent tumour lysis, and correct DIC with platelets and plasma components as needed.
Too many cells, stiff cells or too much protein?
| Feature | Leukostasis (AML) | Protein hyperviscosity (Waldenström) | Too many red cells (polycythaemia) |
|---|---|---|---|
| What thickens the blood | Large rigid blasts | Large IgM molecules | High haematocrit |
| Main organs | Lungs and brain | Eyes, brain, mucosa | Brain, clotting in arteries and veins |
| Typical clue | Very high blast count, low oxygen, infiltrates | Nosebleeds, blurred vision, sausage veins on fundoscopy | Red face, itch after a warm bath, thrombosis |
| Rapid fix | Hydroxyurea or chemotherapy; leukapheresis in selected cases | Plasma exchange | Venesection |
| Avoid | Red cell transfusion; leukapheresis in APL | Red cell transfusion before plasma exchange | Dehydration |
Costly mistakes
- A patient with AML, a blast count of 150 × 10⁹/L and new confusion has a neurological emergency even if the scan is normal.
- The oxygen on an arterial gas may read falsely low because the blasts consume oxygen in the syringe; pulse oximetry is often more reliable.
- Fundoscopy is the quickest bedside test for hyperviscosity: dilated, segmented retinal veins and haemorrhages.
- Platelet transfusions add little to viscosity and can be given when needed for bleeding or DIC.
Tests and next step
- Full count and smear, coagulation tests and fibrinogen, potassium, phosphate, calcium, uric acid, creatinine and LDH.
- Suspected protein hyperviscosity: serum viscosity, protein electrophoresis with immunofixation, IgM level.
- Unexpected high potassium or low oxygen with a very high count: repeat with a rapidly processed sample and check pulse oximetry.
- Chest radiograph, and brain imaging for neurological signs; intensive care review for hypoxia or falling consciousness.
Common traps
- Transfusing red cells to a patient with hyperleukocytosis or IgM hyperviscosity: it thickens the blood and can precipitate stroke or respiratory failure.
- Treating a falsely high potassium or a falsely low arterial oxygen: cells still working in the test tube cause these false results.
- Assuming CLL with a very high count needs urgent leukapheresis: its small cells rarely cause leukostasis.
- Performing leukapheresis in APL: it can worsen the coagulopathy.
- Waiting for the marrow results in a symptomatic patient: lowering the count starts without waiting for them.
Test yourself
Think of the answer, then tap the question to see it.
Why does AML cause leukostasis at lower counts than CLL?
Myeloblasts are large, rigid and sticky, while CLL cells are small and deformable, so the same count of blasts blocks small vessels far more easily.
Why is IgM more likely than IgG to cause hyperviscosity?
IgM is a large pentamer that stays mostly inside the vessels, so a modest amount raises plasma viscosity much more than the smaller IgG.
A patient with a blast count of 200 × 10⁹/L has a haemoglobin that is low. Why is red cell transfusion delayed if possible?
Adding red cells raises the total cell volume and viscosity, which can worsen leukostasis in the lungs and brain.
Why can the arterial oxygen read low in hyperleukocytosis while the pulse oximeter is normal?
The huge number of white cells keeps consuming oxygen in the syringe before analysis, giving a falsely low result.
Elsewhere in DurgiPedia
- Acute myeloid leukaemia
- Plasma cell disorders: MGUS to myeloma
- Acute promyelocytic leukaemia
- Bleeding and clotting emergencies in the ICU (DIC, low platelets, HIT) and tumour lysis: what nurses watch
Connections
In Pharmacology2
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Hyperviscosity Syndrome (StatPearls (NCBI Bookshelf), 2026); Waldenstrom macroglobulinemia (MedlinePlus (U.S. National Library of Medicine), 2026); Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version (National Cancer Institute (NCI), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
